Outlook Therapeutics (OTLK) Gross Margin: 2015-2020
Historic Gross Margin for Outlook Therapeutics (OTLK) over the last 6 years, with Sep 2020 value amounting to 100.00%.
- Outlook Therapeutics' Gross Margin changed negligibly% to 100.00% in Q3 2020 from the same period last year, while for Sep 2020 it was 100.00%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
- According to the latest figures from Q3 2020, Outlook Therapeutics' Gross Margin is 100.00%, which was down 0.00% from 100.00% recorded in Q2 2020.
- Outlook Therapeutics' Gross Margin's 5-year high stood at 100.00% during Q1 2016, with a 5-year trough of 100.00% in Q1 2016.
- Over the past 3 years, Outlook Therapeutics' median Gross Margin value was 100.00% (recorded in 2020), while the average stood at 100.00%.